2019 AIChE Annual Meeting
(156d) CAR-Mediated T Cell Activation: Linking Molecularly-Detailed and Data-Driven Models
Authors
Materials and Methods: Using a mechanistic model of CAR T cell signaling, a heterogeneous population of 10,000 cells was simulated. Cell response was determined using the relative phosphorylated ERK concentration. This response separated the population into two categories: responders and non-responders. To better understand the relationship between protein expression and cell response, a PLS model was developed using the initial protein concentrations as inputs and the response as the output. The data generated from the mechanistic model simulations was used to train and validate the accuracy of the PLS model. Examining the components and the weights of the PLS model allowed us to determine the general influence of each individual protein on the cellâs ability to respond. Since lower weighted inputs have less of an impact on the PLS outputs, proteins with lower weights were removed from the dataset and the PLS model was retrained to further determine which proteins are highly influential to the cell response.
Results and Discussion: From the population simulations, it was found that only about half of the cells in the population could be characterized as responders. A PLS model was developed that could classify this response with high accuracy. Out of the 19 proteins present in the network, only eight (LAT, Gads, SOS, Ras, RAF, MEK, RasGAP, and RasGRP) were found to be highly influential based upon the weights of their initial concentrations. The influence of these proteins on the system was found to match literature descriptions of their biological roles. Interestingly, it was found that the upstream proteins that interact with the CAR had very little influence on whether or not the cell would respond. All of the influential proteins identified are related to the activation of the MAPK pathway and its signal transduction. This approach of using a data-driven model as a way to analyze a mechanistic model allowed for a generalization of model parameters and investigation of their effects on the system as a whole. Additionally, we have used the data-driven model as a means of easing the computational burden of simulating the full mechanistic model. This enables a multi-scale framework to study immunotherapy, drug resistance, and the effects of tumor cell mutations.